Post-inflammatory hyperpigmentation (PIH) is a darkening of the skin in the treated area following laser tattoo removal. It occurs when melanocytes — pigment-producing cells — are stimulated by the inflammatory response to laser treatment and produce excess melanin. While PIH is usually temporary and can be treated, it is an unwanted complication that can temporarily make the treatment site appear darker than the surrounding skin. Understanding its causes and prevention is essential for anyone considering laser tattoo removal, especially those with medium to dark skin tones.
The Mechanism of PIH
Laser treatment induces acute inflammation in treated tissue. The inflammatory mediators released — prostaglandins, leukotrienes, cytokines — can stimulate melanocytes at the dermal-epidermal junction to upregulate melanin synthesis. This is the same mechanism that causes skin darkening after any form of skin injury or inflammation: acne scars, insect bites, and surgical wounds can all cause PIH, not just laser treatment. The laser simply induces a particularly controlled form of skin injury.
Epidermal PIH — the more common form — appears as flat tan-to-dark brown discoloration in the treatment zone, reflecting excess melanin deposited in the epidermis. Dermal PIH, less common and more persistent, involves melanin deposited in dermal macrophages following disruption of the DEJ; it appears as gray-brown or gray-blue discoloration and responds more slowly to treatment.
Risk Factors for PIH
Fitzpatrick Types III–VI are at significantly higher risk for PIH due to higher baseline melanin content and more reactive melanocytes. Recent UV exposure (tan skin) dramatically increases PIH risk — melanocytes that have been primed by UV light respond more intensely to subsequent inflammatory stimuli. Aggressive treatment settings (high fluence, insufficient cooling) produce more intense inflammation and proportionally greater melanocyte stimulation. Treating through an active tan, or sessions scheduled too close together before the skin has fully recovered, increase cumulative inflammatory burden.
Prevention Strategies
The most effective PIH prevention is pre-treatment sun avoidance for 4–6 weeks and consistent broad-spectrum SPF 50+ sunscreen use before and after sessions. Test spots allow assessment of individual PIH tendency before full treatment. Conservative fluence selection — particularly on first sessions with an unknown skin response — is preferable to aggressive settings. Effective epidermal cooling during treatment reduces the temperature rise in melanocyte-containing tissue. Some clinicians recommend pre-treatment topical hydroquinone (2–4%) for 4–6 weeks in high-risk patients to suppress melanocyte activity before laser exposure.
Treatment When PIH Occurs
Most epidermal PIH resolves spontaneously over weeks to months with consistent photoprotection. First-line topical treatments include hydroquinone (the most evidence-supported depigmenting agent), azelaic acid (15–20%), kojic acid, and combinations. Topical retinoids accelerate epidermal turnover, helping shed pigment-laden keratinocytes faster. Chemical peels using glycolic acid or trichloroacetic acid (performed by a dermatologist) can accelerate PIH resolution by removing the pigment-containing epidermal layers. Dermal PIH is more stubborn and may require months of topical treatment and strict UV protection before clinical improvement is apparent. Laser treatment of the PIH itself (using very low fluence, gentle protocols) is sometimes employed by experienced practitioners but should be approached with caution as re-treating inflamed or PIH-affected skin risks worsening the pigmentation.